Casey Toohill recently announced his retirement after a six-year NFL career, and the 30-year-old former defensive end admits to playing with a certain amount of “existential dread” when it came to the pounding his brain took during years of competitive football.
Sure, he knew of the health risks. But outside of quitting the sport, was there anything anyone could really do about it?
Now that his playing days are over, he is encouraged that answers are being sought.
“We have these clinical trials happening — we’re making progress,” said Toohill, now an advocate for former players with head injuries. “We’re trying to help people. We’re not helpless in this situation.”
Toohill became a member last month of the advisory board of the Concussion & CTE Foundation, which is joining with Atlanta’s Emory University School of Medicine to start a clinical trial on whether an FDA-approved medication called baricitinib that reduces inflammation can improve depression and cognitive symptoms in former football players.
